<?xml version="1.0" encoding="UTF-8"?>
<p>California HOFIs inoculated with SLEV/ IMP115 produced significantly lower (p&lt;0.05) daily mean titers in comparison with SLEV-prME/WNV.IC and WNV.IC (
 <xref ref-type="fig" rid="pntd.0006302.g001">Fig 1A</xref>). In contrast, growth of SLEV-prME/WNV.IC was statistically indistinguishable (p&gt;0.05) from WNV.IC (
 <xref ref-type="fig" rid="pntd.0006302.g001">Fig 1A</xref>). Peak mean titers showed a similar pattern where SLEV/IMP115 was 3.5 ± 1.0 log
 <sub>10</sub> PFU/mL and significantly lower (p&lt;0.05) than SLEV-prME/WNV.IC and WNV.IC titers (
 <xref ref-type="fig" rid="pntd.0006302.g002">Fig 2A</xref>). Peak mean titers of SLEV-prME/WNV.IC (6.8 ± 0.6 log
 <sub>10</sub> PFU/mL) and WNV.IC (7.4 ± 1.0 log
 <sub>10</sub> PFU/mL) were statistically indistinguishable (p&gt;0.05) (
 <xref ref-type="fig" rid="pntd.0006302.g002">Fig 2A</xref>). No morbidity or mortality was observed with HOFIs inoculated with WNV.IC or SLEV/IMP115 (
 <xref ref-type="fig" rid="pntd.0006302.g003">Fig 3A</xref>). In contrast, only two HOFIs died by 5 dpi and only one HOFI survived in the SLEV-prME/WNV.IC group by 7dpi (
 <xref ref-type="fig" rid="pntd.0006302.g003">Fig 3A</xref>).
</p>
